Two dozen journalists. A pile of pages that would reach the top of the Empire State Building. And an effort to find the next revelation in a sprawling case.

From forest management to climate resilience, the organization is exporting Israeli expertise while learning innovative ...

Quantum communication has long promised unbreakable encryption, but the hardware has struggled to escape the lab. A new generation of laser-written glass chips is changing that equation, carving three ...

Dementia has long been framed as an inevitable byproduct of aging, something to be managed rather than meaningfully delayed. A sprawling clinical trial of older adults now challenges that assumption, ...

Researchers at the company are trying to understand their A.I. system’s mind—examining its neurons, running it through ...

OpenAI Robotics is like a new chapter in making smart machines. They’ve created a robot called Neo, which is a humanoid robot ...

A new experiment hints that an ape may be able to play pretend like humans do. Scientists studied a bonobo named Kanzi who ...

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

In this unusually eventful — mostly not in good ways — year for higher education, it’s salutary to be reminded how much good ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The Trump administration is planning to use artificial ...

Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon with biology through artificial-intelligence-powered drug development. The ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Two reports forecasting Boston's ...